HPV testing alone is an effective alternative to current cervical cancer screening methods that use a Pap smear, or Pap smear-plus HPV test.
Ted J. Kaptchuk, professor of medicine at Harvard Medical School and director of the Harvard-wide Program in Placebo Studies and the Therapeutic Encounter at Beth Israel Deaconess Medical Center, will present “Placebo Effects: how is medicine more than drugs and surgery?” from noon – 1:00 p.m. on Tuesday, Jan. 13.
The UAB Cancer Center and Alabama State University receive $1.5 million NIH grant to create partnership and reduce cancer health disparities.
Keshav K. Singh, Ph.D., an expert on the roles of mitochondria in cancer, mitochondrial disease and aging, is one of 12 extramural researchers invited to a National Cancer Institute Mitochondrial Information Transfer Strategic Workshop.
October is Breast Cancer Awareness Month; several local activities support the cause.
Two highly acclaimed cancer researchers, Ravi Bhatia, M.D., and Smita Bhatia, M.D., MPH, will join UAB in January 2015.
In January, Ravi Bhatia, M.D., will take the helm as director of the Division of Hematology and Oncology and as deputy director of the UAB Comprehensive Cancer Center.
Smita Bhatia, M.D., MPH, a distinguished pediatric oncologist with a strong interest in cancer outcomes, will be join the School of Medicine to tackle the health challenges cancer survivors face during and after treatment.
HudsonAlpha and the UAB Cancer Center establish joint cancer research consortium focusing on cancer genomics, with multiple hires expected.
Christopher Willey, M.D., Ph.D., receives a crucial ACS research grant to further his novel work on the MARCKS protein in relation to brain cancer.